Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy

Bipolar Disorders

Volumn 2, Issue 3 PART 2, 2000, Pages 249-255

  Pande, Atul C ^a   Crockatt, Jerri G ^a   Janney, Carol A ^a   Werth, John L ^a   Tsaroucha, Georgia ^a   Altshuler, L ^a   Gerner, R ^a   Bowden, C L ^a   Rhodes, L ^a   Calabrese, J R ^a   Shelton, M ^a   Dunner, D L ^a   Hendrickson, H ^a   Gyulai, L ^a   Hirschfeld, R ^a   Kaplan, G B ^a   Ketter, T ^a   Lydiard, R B ^a   McElroy, S L ^a   Keck Jr , P E ^a   Sachs, G ^a   Suppes, P ^a   Zajecka, J ^a   Zarate, C ^a   more..

^a PFIZER INC   (United States)

Author keywords

Bipolar disorder; Clinical trial; Gabapentin; Mania; Placebo controlled; Trial methods

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; LITHIUM CARBONATE; TRANQUILIZER; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETIC ACIDS; ADOLESCENT; ADULT; AGED; AMINES; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0034278763     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2000.20305.x     Document Type: Article

References (18)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151: 1a-36a.
2. Keck PE, Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P. Twelve-month outcome of bipolar patients following hospitalizationfor a manic or mixed episode. Am J Psychiatry 1998; 155: 646-652.
3. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder [letter]. J Neuropsychiatry Clin Neurosci 1997; 2: 301.
4. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder [letter]. Am J Psychiatry 1997; 154: 291-292.
5. McElroy SL, Soutullo CA, Keck PE, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9: 99-103.
6. Young LT, Robb JC, Patelis-Siotis I, McDonald C, Joffe RT. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42: 851-853.
7. Erfurth A, Kammerer C, Grunze H, Normann C, Walden J. An open label study of gabapentin in the treatment of acute mania. J Psychiatric Res 1998; 32: 261-264.
8. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disorders 1998; 49: 229-233.
9. Dimond KR, Pande AC, LaMoreaux L, Pierce MW. Effect of gabapentin on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiat 1996; 20: 407-417.
10. Young RC, Biggs JT, Ziegle VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978; 133: 429-435.
11. Hamilton MW. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-60.
12. Hamilton MW. The assessment of anxiety states by rating. Brit J Med Psychol 1959; 32: 10-16.
13. Bauer MS, Crits-Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, Cacciola J, Whybrow PC. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry 1991; 48: 807-812.
14. Leverick GS, Post RM. The Life Chart Manual (self version). Bethesda, MD: NIMH Biological Psychiatry Branch, 1995.
15. Ware JE, Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
16. SAS Institute, Inc. SAS/STAT® Software: Changes and Enhancements Through Release 6.12. Cary, NC: SAS Institute INC.
17. Pande AC, Davidson JRT, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999; 19: 341-348.
18. Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment in panic disorder. J Clin Psychopharmacol (in press).